United Airlines To Slash 16,370 Jobs As Air Travel Sinks
J&J Abandons Influenza A Treatment Program After Interim Analysis
Steroids cut death rates among critically ill Covid-19 patients, major study finds
What happens to the plastic you recycle? Researchers lift the lid
'Science Deniers'? - Delaying Herd Immunity Is Costing Lives
A ‘Human’ Touch vs. COVID-19
GSK and Vir take COVID-19 antibody therapy into clinic
Bristol Myers Scores FDA Nod For Acute Myeloid Leukemia Treatment
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
NIH Attacks FDA Over 'Premature' Approval Of 'Trump-Backed' Convalescent Plasma
Tuesday's Market Snapshot: Here's What You Need To Know Right Now
How to use precision medicine to personalize COVID-19 treatment according to the patient's genes
Medical Groups Can Fight Possibly Deadly COVID-19 Vaccine
Athenex Spikes 12% On FDA Application For Oral Breast Cancer Treatment
Sanofi Says Kevzara Drug Fails To Meet Endpoints in Covid-19 Study
News briefing: Novartis hands off NASH drug to biotech collaborator, also plans to build new Basel production unit
A history of the pharmaceutical industry
Mechanical Ventilators Market to Cross the USD 2.5 Billion Frontier by 2026
Medtronic's First-Of-Its Kind Diabetes System For Young Children Approved
People with less body response to stress task had more PTSD signs after COVID-19 began
Lessons Learned from Chicago’s Landmark Old Post Office Redevelopment
College students access eating disorders therapy via phone app
Vir Bio and GSK Join the Race for a Covid-19 Monoclonal Antibody Therapy
Antibody blockade effective in treatment of severe COVID-19
COVID-19 clues in a community's sewage: 4 questions answered about watching wastewater for coronavirus
S&P Set To Open At New Record High; Tesla, Apple Trade Post-Split
Merck vs Eli Lilly: Which Pharma Stock Is A Better Pick?
Unfazed by slow rollout, Nestlé buys out Aimmune and its peanut allergy med for $2.6B
Nevada Lab Confirms First Case Of COVID-19 Reinfection Documented In US
FDA commissioner willing to fast-track Covid-19 vaccine: FT